JP2004538272A5 - - Google Patents

Info

Publication number

JP2004538272A5

JP2004538272A5 JP2003505336A JP2003505336A JP2004538272A5 JP 2004538272 A5 JP2004538272 A5 JP 2004538272A5 JP 2003505336 A JP2003505336 A JP 2003505336A JP 2003505336 A JP2003505336 A JP 2003505336A JP 2004538272 A5 JP2004538272 A5 JP 2004538272A5

Authority

JP

Japan

Prior art keywords

disease

pharmaceutical composition

angiogenesis

seq

heart failure

Prior art date

2002-06-14

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 230000033115 angiogenesis Effects 0.000 claims 10
• 239000008194 pharmaceutical composition Substances 0.000 claims 10
• 206010019280 Heart failures Diseases 0.000 claims 8
• 239000002773 nucleotide Substances 0.000 claims 7
• 125000003729 nucleotide group Chemical group 0.000 claims 7
• 206010020772 Hypertension Diseases 0.000 claims 6
• 238000003745 diagnosis Methods 0.000 claims 5
• 206010002329 Aneurysm Diseases 0.000 claims 4
• 206010051113 Arterial restenosis Diseases 0.000 claims 4
• 201000001320 Atherosclerosis Diseases 0.000 claims 4
• 208000011231 Crohn disease Diseases 0.000 claims 4
• 208000001132 Osteoporosis Diseases 0.000 claims 4
• 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 claims 4
• 208000018262 Peripheral vascular disease Diseases 0.000 claims 4
• 201000004681 Psoriasis Diseases 0.000 claims 4
• 208000012322 Raynaud phenomenon Diseases 0.000 claims 4
• 208000017442 Retinal disease Diseases 0.000 claims 4
• 208000035868 Vascular inflammations Diseases 0.000 claims 4
• 230000001684 chronic effect Effects 0.000 claims 4
• 206010025226 lymphangitis Diseases 0.000 claims 4
• 208000002780 macular degeneration Diseases 0.000 claims 4
• 208000010125 myocardial infarction Diseases 0.000 claims 4
• 108020004707 nucleic acids Proteins 0.000 claims 4
• 102000039446 nucleic acids Human genes 0.000 claims 4
• 150000007523 nucleic acids Chemical class 0.000 claims 4
• 230000007170 pathology Effects 0.000 claims 4
• 208000037803 restenosis Diseases 0.000 claims 4
• 206010039073 rheumatoid arthritis Diseases 0.000 claims 4
• 230000036573 scar formation Effects 0.000 claims 4
• 201000005060 thrombophlebitis Diseases 0.000 claims 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
• 102100025087 Insulin receptor substrate 1 Human genes 0.000 claims 3
• 101710201824 Insulin receptor substrate 1 Proteins 0.000 claims 3
• 206010064930 age-related macular degeneration Diseases 0.000 claims 3
• 201000010099 disease Diseases 0.000 claims 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
• 208000019622 heart disease Diseases 0.000 claims 3
• 230000002401 inhibitory effect Effects 0.000 claims 3
• 108090000623 proteins and genes Proteins 0.000 claims 3
• 206010002383 Angina Pectoris Diseases 0.000 claims 2
• 206010007559 Cardiac failure congestive Diseases 0.000 claims 2
• 201000009273 Endometriosis Diseases 0.000 claims 2
• 206010025282 Lymphoedema Diseases 0.000 claims 2
• 206010029113 Neovascularisation Diseases 0.000 claims 2
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
• 208000003782 Raynaud disease Diseases 0.000 claims 2
• 206010038923 Retinopathy Diseases 0.000 claims 2
• 208000031737 Tissue Adhesions Diseases 0.000 claims 2
• 239000013543 active substance Substances 0.000 claims 2
• 208000007502 anemia Diseases 0.000 claims 2
• 210000004696 endometrium Anatomy 0.000 claims 2
• 239000012634 fragment Substances 0.000 claims 2
• 208000028867 ischemia Diseases 0.000 claims 2
• 208000002502 lymphedema Diseases 0.000 claims 2
• 208000003265 stomatitis Diseases 0.000 claims 2
• 230000003213 activating effect Effects 0.000 claims 1
• 239000004480 active ingredient Substances 0.000 claims 1
• 230000002491 angiogenic effect Effects 0.000 claims 1
• 230000000692 anti-sense effect Effects 0.000 claims 1
• 239000003795 chemical substances by application Substances 0.000 claims 1
• 230000000295 complement effect Effects 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 230000001926 lymphatic effect Effects 0.000 claims 1
• 239000000203 mixture Substances 0.000 claims 1
• 208000017520 skin disease Diseases 0.000 claims 1
• 239000000126 substance Substances 0.000 claims 1